Skip to main content
PMC home page
Heart logoLink to Heart
. 2000 Mar;83(3):307–311. doi: 10.1136/heart.83.3.307

Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function

M Iemura 1, M Ishii 1, T Sugimura 1, T Akagi 1, H Kato 1
PMCID: PMC1729327  PMID: 10677411

Abstract

OBJECTIVES—To investigate the long term consequences of regressed aneurysms after Kawasaki disease, using follow up coronary angiography; to assess the vascular wall morphology at the site of the aneurysms by intravascular ultrasound imaging; and to evaluate the function of the affected vessels using intracoronary infusions of acetylcholine and isosorbide dinitrate.
DESIGN—33 patients were studied, 27 with previous Kawasaki disease and six with congenital heart disease. All Kawasaki disease patients were followed for more than 10 years from disease onset. The 33 patients comprised four groups: group 1 included 13 Kawasaki disease patients with a total of 23 sites of regressed large sized (⩾ 4 mm) coronary aneurysms; group 2 included 13 Kawasaki disease patients with 22 sites of regressed small sized (< 4 mm) coronary aneurysms (four patients had sites of both large and small sized aneurysms); group 3 included a further five Kawasaki disease patients with 25 normal coronary angiography sites in the acute stage of Kawasaki disease; and group 4 comprised the six patients with congenital heart disease as controls, with a total of 27 normal coronary angiography sites. During coronary angiography, 15 µg of acetylcholine and 0.5 mg isosorbide dinitrate were infused into the coronary artery. The luminal diameter at the sites was measured using a cine-videodensitometric analyser, to assess the distensibility of the coronary artery wall.
RESULTS—Coronary angiography in all 22 patients in groups 1 and 2 and in all the patients in group 3 was normal, with no stenoses and no irregularity of the arterial wall. However, the intravascular ultrasound imaging in groups 1 and 2 showed various degrees of the intimal thickening. In groups 1 and 2, there was significantly more vascular constriction with acetylcholine, and poorer dilatation with isosorbide dinitrate than in groups 3 or 4 (each p < 0.05, respectively). There was no difference between group 3 and group 4 in response to either acetylcholine or isosorbide dinitrate,
CONCLUSIONS—There is evidence of persisting abnormal vascular wall morphology and vascular dysfunction at the site of regressed coronary aneurysms in patients with previous Kawasaki disease. These patients should be counselled to avoid potential risk factors for atherosclerosis, and long term follow up is needed into adult life.


Keywords: Kawasaki disease; coronary aneurysm; atherosclerosis; intravascular ultrasound

Full Text

The Full Text of this article is available as a PDF (122.6 KB).

Figure 1  .

Figure 1  

Open in a new tab

Coronary angiograms and intravascular ultrasound images of a patient in group 1. First angiography 55 days after onset of Kawasaki disease (A). Follow up angiography 14 years after the onset of Kawasaki disease: in steady state (B); after intracoronary infusion of acetylcholine (C); and after intracoronary infusion of isosorbide dinitrate (D); intravascular ultrasonographic images at the regressed site of coronary artery (E).

Figure 2  .

Figure 2  

Open in a new tab

Mean percentage change in the diameter of the coronary artery after intracoronary infusion of acetylcholine (ACh) and isosorbide dinitrate (ISDN) in each group. Error bars = SEM. *p < 0.05 (ACh); **p < 0.05 (ISDN).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akagi T., Kato H., Inoue O., Sato N. Salicylate treatment in Kawasaki disease: high dose or low dose? Eur J Pediatr. 1991 Jul;150(9):642–646. doi: 10.1007/BF02072625. [DOI] [PubMed] [Google Scholar]
  2. Anderson T. J., Meredith I. T., Ganz P., Selwyn A. P., Yeung A. C. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol. 1994 Aug;24(2):555–566. doi: 10.1016/0735-1097(94)90316-6. [DOI] [PubMed] [Google Scholar]
  3. Dhillon R., Clarkson P., Donald A. E., Powe A. J., Nash M., Novelli V., Dillon M. J., Deanfield J. E. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996 Nov 1;94(9):2103–2106. doi: 10.1161/01.cir.94.9.2103. [DOI] [PubMed] [Google Scholar]
  4. Egashira K., Inou T., Hirooka Y., Yamada A., Urabe Y., Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993 Jun 10;328(23):1659–1664. doi: 10.1056/NEJM199306103282302. [DOI] [PubMed] [Google Scholar]
  5. Feelisch M. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur Heart J. 1993 Nov;14 (Suppl 1):123–132. [PubMed] [Google Scholar]
  6. Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., Tamura T., Hirose O., Manabe Y., Yokoyama T. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984 Nov 10;2(8411):1055–1058. doi: 10.1016/s0140-6736(84)91504-6. [DOI] [PubMed] [Google Scholar]
  7. Harrison D. G., Bates J. N. The nitrovasodilators. New ideas about old drugs. Circulation. 1993 May;87(5):1461–1467. doi: 10.1161/01.cir.87.5.1461. [DOI] [PubMed] [Google Scholar]
  8. Hirose S., Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr. 1978 Aug 17;129(1):17–27. doi: 10.1007/BF00441370. [DOI] [PubMed] [Google Scholar]
  9. Hodgson J. M., Marshall J. J. Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation. 1989 May;79(5):1043–1051. doi: 10.1161/01.cir.79.5.1043. [DOI] [PubMed] [Google Scholar]
  10. Ishii M., Kato H., Kawano T., Akagi T., Maeno Y., Sugimura T., Hashino K., Takagishi T. Evaluation of pulmonary artery histopathologic findings in congenital heart disease: an in vitro study using intravascular ultrasound imaging. J Am Coll Cardiol. 1995 Jul;26(1):272–276. doi: 10.1016/0735-1097(95)00154-r. [DOI] [PubMed] [Google Scholar]
  11. Kato H., Akagi T., Sugimura T., Sato N., Kazue T., Hashino K., Nishiyori A., Sakaguchi M. Kawasaki disease. Coron Artery Dis. 1995 Mar;6(3):194–206. [PubMed] [Google Scholar]
  12. Kato H., Ichinose E., Yoshioka F., Takechi T., Matsunaga S., Suzuki K., Rikitake N. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol. 1982 May;49(7):1758–1766. doi: 10.1016/0002-9149(82)90256-9. [DOI] [PubMed] [Google Scholar]
  13. Kato H., Inoue O., Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev. 1988 Jan;9(7):209–217. doi: 10.1542/pir.9-7-209. [DOI] [PubMed] [Google Scholar]
  14. Kato H., Koike S., Yamamoto M., Ito Y., Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975 Jun;86(6):892–898. doi: 10.1016/s0022-3476(75)80220-4. [DOI] [PubMed] [Google Scholar]
  15. Kato H., Koike S., Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics. 1979 Feb;63(2):175–179. [PubMed] [Google Scholar]
  16. Kato H., Sugimura T., Akagi T., Sato N., Hashino K., Maeno Y., Kazue T., Eto G., Yamakawa R. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996 Sep 15;94(6):1379–1385. doi: 10.1161/01.cir.94.6.1379. [DOI] [PubMed] [Google Scholar]
  17. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974 Sep;54(3):271–276. [PubMed] [Google Scholar]
  18. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 1967 Mar;16(3):178–222. [PubMed] [Google Scholar]
  19. Ludmer P. L., Selwyn A. P., Shook T. L., Wayne R. R., Mudge G. H., Alexander R. W., Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986 Oct 23;315(17):1046–1051. doi: 10.1056/NEJM198610233151702. [DOI] [PubMed] [Google Scholar]
  20. Mitani Y., Okuda Y., Shimpo H., Uchida F., Hamanaka K., Aoki K., Sakurai M. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation. 1997 Jul 15;96(2):454–461. [PubMed] [Google Scholar]
  21. Nakano H., Ueda K., Saito A., Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol. 1985 Nov 15;56(13):846–851. doi: 10.1016/0002-9149(85)90767-2. [DOI] [PubMed] [Google Scholar]
  22. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  23. Sasaguri Y., Kato H. Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr. 1982 Feb;100(2):225–231. doi: 10.1016/s0022-3476(82)80639-2. [DOI] [PubMed] [Google Scholar]
  24. Sugimura T., Kato H., Inoue O., Fukuda T., Sato N., Ishii M., Takagi J., Akagi T., Maeno Y., Kawano T. Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994 Jan;89(1):258–265. doi: 10.1161/01.cir.89.1.258. [DOI] [PubMed] [Google Scholar]
  25. Sugimura T., Kato H., Inoue O., Takagi J., Fukuda T., Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992 Nov;121(5 Pt 1):684–688. doi: 10.1016/s0022-3476(05)81893-1. [DOI] [PubMed] [Google Scholar]
  26. Suzuki A., Kamiya T., Arakaki Y., Kinoshita Y., Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 1994 Oct 15;74(8):822–824. doi: 10.1016/0002-9149(94)90446-4. [DOI] [PubMed] [Google Scholar]
  27. Suzuki A., Yamagishi M., Kimura K., Sugiyama H., Arakaki Y., Kamiya T., Miyatake K. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol. 1996 Feb;27(2):291–296. doi: 10.1016/0735-1097(95)00447-5. [DOI] [PubMed] [Google Scholar]
  28. Yamakawa R., Ishii M., Sugimura T., Akagi T., Eto G., Iemura M., Tsutsumi T., Kato H. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol. 1998 Apr;31(5):1074–1080. doi: 10.1016/s0735-1097(98)00033-3. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES